Oral delivery of tumor‐targeting Salmonella for cancer therapy in murine tumor models
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Tumor‐targeting bacteria have been investigated intensively in recent years as anticancer agents. To ensure the reliability of infection, bacteria have conventionally been injected intravenously or intraperitoneally into animals or humans. However, systemic infection of bacteria is rather inconvenient and carries the risk of obvious toxicity. Here we tested whether Salmonella typhimurium VNP20009, a tumor‐targeting strain, could be administrated orally for tumor therapy. Tumor‐targeting potential, antitumor effects, as well as toxicity of orally administrated VNP20009 were investigated in this study. Oral delivery of VNP20009 not only exhibited high tumor‐targeting potential, but also led to a significant anticancer effect by delaying tumor growth and prolonging survival in murine tumor models. As part of combination therapy, orally administrated bacteria notably improved the antitumor effect of cyclophosphamide. In vitro and in vivo studies showed that VNP20009 significantly induced tumor cell apoptosis. No obvious toxicity was observed during the treatments with oral inoculation of VNP20009. Comparative analysis of toxicity in tumor‐bearing and tumor‐free mice further revealed that orally administrated Salmonella had high safety compared to conventional systemic infection of bacteria. The findings indicated that oral administration of tumor‐targeting bacteria is effective and safe. This approach provides a novel avenue in the application of bacteria as a potential antitumor agent. (Cancer Sci 2007; 98: 1107–1112)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models
Lee, C., Wu, C., & Shiau, A. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.626 · Cited by 93
Cited by
Engineering the perfect (bacterial) cancer therapy
Forbes, N. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2934 · Cited by 905
“Following oral administration in mice, Salmonella preferentially accumulated in tumours and maintained its anticancer effect”
BackgroundTumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
Sedighi, M., Zahedi Bialvaei, A., Hamblin, M. R., Ohadi, E., Asadi, A., Halajzadeh, M., Lohrasbi, V., Mohammadzadeh, N., Amiriani, T., Krutova, M., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2148 · Cited by 308
Engineering Nanoparticle-Coated Bacteria as Oral DNA Vaccines for Cancer Immunotherapy
Hu, Q., Wu, M., Fang, C., Cheng, C., Zhao, M., Fang, W., Chu, P. K., Ping, Y., & Tang, G. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b00570 · Cited by 286
Galanzha, E. I., Shashkov, E. V., Spring, P. M., Suen, J. Y., & Zharov, V. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4900 · Cited by 259
Metadata
- Authors
- Jia, L., Wei, D., Sun, Q., Huang, Y., Wu, Q., & Hua, Z.
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2007-05-13
- Volume
- 98
- Issue
- 7
- Pages
- 1107-1112
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W2022364228
- Cited by
- 59
- References
- 2
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oral delivery of tumor‐targeting Salmonella for cancer therapy in murine tumor models. https://app.cochat.ai/papers/10.1111/j.1349-7006.2007.00503.x
- The paper
- Jia, L., Wei, D., Sun, Q., Huang, Y., Wu, Q., & Hua, Z. (2007). Oral delivery of tumor‐targeting Salmonella for cancer therapy in murine tumor models. Cancer Science. https://doi.org/10.1111/j.1349-7006.2007.00503.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.